Jeff Yass’s First Tracks Biotherapeutics TRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.41M Buy
39,691
+18,562
+88% +$725K ﹤0.01% 7136
2026
Q2
$425K Buy
+21,129
New +$395K ﹤0.01% 10268

Other funds holding TRAX

Jeff Yass's TRAX Position: Q3 2026 in Review

Jeff Yass increased its First Tracks Biotherapeutics (TRAX) stake by 88% in Q3 2026, buying an estimated $725K and bringing the position to 39,691 shares worth $1.41M. The position accounts for ﹤0.01% of the portfolio, ranked #7136.

Jeff Yass first reported a position in TRAX in Q2 2026 and has held it in 2 quarters since. 182 funds tracked by Wall St. Rank hold TRAX as of Q3 2026.

  • Jeff Yass held 39,691 shares of First Tracks Biotherapeutics worth $1.41M as of Q3 2026.
  • Jeff Yass bought 18,562 First Tracks Biotherapeutics shares in Q3 2026, an estimated $725K.
  • First Tracks Biotherapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #7136 holding.
  • Jeff Yass first reported a position in First Tracks Biotherapeutics in Q2 2026 and has held it in 2 quarters since.
  • 182 funds tracked by Wall St. Rank held First Tracks Biotherapeutics as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.